Dergiler / Respiratory Case Reports / 2019 / Cilt: 8 - Sayı: 3

Pulmonary Spindle Cell Sarcomatoid Carcinoma: A Case Report

Pulmoner İğ Hücreli Sarkomatoid Karsinom: Olgu Sunumu

Sayfa
107–110
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

After radiochemotherapy, the patient showed an initial partial response and then tumor progression.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Primary lung sarcomatoid carcinoma (SC) is a rare malignant tumor, with spindle-cell SC representing one subtype of this histological category, only few cases of which have been reported in literature.
📊
Temel Bulgular & Veri:Herein we report on the case of a 40-year-old patient with a complaint of chest pain who was found to have a left apical mass in a chest computed tomography (CT).
💡
Sonuç & Katkı:After radiochemotherapy, the patient showed an initial partial response and then tumor progression.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Primary lung sarcomatoid carcinoma (SC) is a rare malignant tumor, with spindle-cell SC representing one subtype of this histological category, only few cases of which have been reported in literature. The treatment and prognosis of pulmonary SC have yet to be clearly determined. Herein we report on the case of a 40-year-old patient with a complaint of chest pain who was found to have a left apical mass in a chest computed tomography (CT). CT-guided lung biopsy and immunohistochemistry confirmed the diagnosis of spindle-cell SC. After radiochemotherapy, the patient showed an initial partial response and then tumor progression.

Abstract

Primer akciğer sarkomatoid karsinomu (SC) bir nadir görülen maling tümörlerden olup iğ hücreli SC, bu histolojik kategorinin bir alt türünü temsil eder. Literatürde sadece birkaç olgu bildirilmiştir. Tedavi ve prognoz, pulmoner SC için net olarak belirlenmemiştir. Burada, bilgisayarlı toraks tomografide (BT) sol apikal kitle saptanan ve göğüs ağrısı araştırması yapılan 40 yaşındaki bir hastayı sunuyoruz. BT eşliğinde yapılan akciğer biyopsisi ve immünhistokimya inceleme sonunda hastaya iğ hücreli SC tanısı kondu. Radyo-kemoterapi uygulandı. Başlangıçta kısmi bir cevap alınmakla beraber sonra bir tümör progresyon gösterdi.

🔖

Bu Makaleye Atıf Yap

FAHEM, N., SAAD, A. B., KADDOUSSI, R., NJIMA, M., MIGAOU, A., MHAMED, S. C., JOOBEUR, S., ROUATBI, N. (2019). Pulmonary Spindle Cell Sarcomatoid Carcinoma: A Case Report. Respiratory Case Reports, Cilt: 8 - Sayı: 3, 107–110. https://ajindex.com/articles/300643

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Steuer CE, Behera M, Liu Y, Fu C, Gillespie TW, Saba NF, et al. Pulmonary Sarcomatoid carcinoma: an analysis of the national cancer data base. Clin Lung Cancer 2017; 18:286-92. [CrossRef] 2. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10:1243-60. [CrossRef] 3. Lin Y, Yang H, Cai Q, Wang D, Rao H, Lin S, et al. Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma. Am J Clin Oncol 2016; 39:215-22. [CrossRef] 4. Morimoto M, Osaki T, Kodate M, Nagaie T, Yamamoto H, Oya M. Spindle cell carcinoma of the lung. Gen Thorac Cardiovasc Surg 2011; 59:129-32. [CrossRef] 5. Karim NA, Schuster J, Eldessouki I, Gaber O, Namad T, Wang J, et al. Pulmonary sarcomatoid carcinoma: University of Cincinnati experience. Oncotarget 2018; 9:4102-8. [CrossRef] 6. Ung M, Rouquette I, Filleron T, Taillandy K, Brouchet L, Bennouna J, et al. Characteristics and clinical cutcomes of sarcomatoid carcinoma of the lung. Clin Lung Cancer 2016; 17:391-7. [CrossRef] 7. Mochizuki T, Ishii G, Nagai K, Yoshida J, Nishimura M, Mizuno T, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol 2008; 32:1727-35. [CrossRef] 8. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 2007; 84:973-80. [CrossRef] 9. Huang SY, Shen SJ, Li XY. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51cases. World J Surg Oncol 2013; 11:252. [CrossRef] 10. Braham E, Ben Rejeb H, Aouadi S, Kilani T, El Mezni F. Pulmonary carcinosarcoma with heterologous component: report of two cases with literature review. Ann Transl Med 2014; 2:41. [CrossRef] 11. Vieira T, Girard N, Ung M, Monnet I, Cazes A, Bonnette P, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. J Thorac Oncol 2013; 8:1574-7. [CrossRef] 12. Maneenil K, Xue Z, Liu M, Boland J, Wu F, Stoddard SM, et al. Sarcomatoid carcinoma of the lung: The Mayo Clinic Experience in 127 Patients. Clin Lung Cancer 2018; 19:e323-e333. [CrossRef] 13. Gu L, Xu Y, Chen Z, Pan Y, Lu S. Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma. Biomed Pharmacother 2015; 76:134-40. [CrossRef]